1. Home
  2. ATEN vs COLL Comparison

ATEN vs COLL Comparison

Compare ATEN & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo A10 Networks Inc.

ATEN

A10 Networks Inc.

HOLD

Current Price

$17.49

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$46.21

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATEN
COLL
Founded
2004
2002
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
ATEN
COLL
Price
$17.49
$46.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$21.50
$47.50
AVG Volume (30 Days)
734.7K
483.2K
Earning Date
02-03-2026
02-26-2026
Dividend Yield
1.36%
N/A
EPS Growth
4.68
N/A
EPS
0.69
1.63
Revenue
$284,406,000.00
$757,067,000.00
Revenue This Year
$12.37
$26.35
Revenue Next Year
$8.10
$3.67
P/E Ratio
$25.42
$28.10
Revenue Growth
10.27
26.34
52 Week Low
$13.81
$23.23
52 Week High
$21.90
$50.79

Technical Indicators

Market Signals
Indicator
ATEN
COLL
Relative Strength Index (RSI) 43.68 46.54
Support Level $17.21 $44.51
Resistance Level $17.98 $50.79
Average True Range (ATR) 0.34 1.36
MACD -0.09 -0.66
Stochastic Oscillator 19.53 29.95

Price Performance

Historical Comparison
ATEN
COLL

About ATEN A10 Networks Inc.

A10 Networks Inc is a provider of security and infrastructure solutions for on-premises, hybrid cloud, and edge-cloud environments of its multinational enterprise, communication, cloud and web service provider customers who strive to provide business-critical applications and networks that are secure, available, and efficient. As cyber-attacks increase in volume and complexity, the company integrates security and artificial intelligence (AI) enabled capabilities in its solutions that enable its customers to continue to adapt to market trends in hybrid cloud, AI-ready data centers and the ever-increasing need for high-performance, high availability and low latency. The company generates the maximum of its revenue from Americas.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: